Abstract:Caves are ubiquitous subterranean voids, accounting for a still largely unexplored surface of the Earth underground. Due to the absence of sunlight and physical segregation, caves are naturally colonized by microorganisms that have developed distinctive capabilities to thrive under extreme conditions of darkness and oligotrophy. Here, the microbiomes colonizing three frequently studied cave types, i.e., limestone, sulfuric acid speleogenetic (SAS), and lava tubes among volcanic caves, have comparatively been reviewed. Geological configurations, nutrient availability, and energy flows in caves are key ecological drivers shaping cave microbiomes through photic, twilight, transient, and deep cave zones. Chemoheterotrophic microbial communities, whose sustenance depends on nutrients supplied from outside, are prevalent in limestone and volcanic caves, while elevated inorganic chemical energy is available in SAS caves, enabling primary production through chemolithoautotrophy. The 16S rRNA-based metataxonomic profiles of cave microbiomes were retrieved from previous studies employing the Illumina platform for sequencing the prokaryotic V3-V4 hypervariable region to compare the microbial community structures from different cave systems and environmental samples. Limestone caves and lava tubes are colonized by largely overlapping bacterial phyla, with the prevalence of Pseudomonadota and Actinomycetota , whereas the co-dominance of Pseudomonadota and Campylobacterota members characterizes SAS caves. Most of the metataxonomic profiling data have so far been collected from the twilight and transient zones, while deep cave zones remain elusive, deserving further exploration. Integrative approaches for future geomicrobiology studies are suggested to gain comprehensive insights into the different cave types and zones. This review also poses novel research questions for unveiling the metabolic and genomic capabilities of cave microorganisms, paving the way for their potential biotechnological applications.

The cave microbiome as a source for drug discovery: Reality or pipe dream?

Cave Microbes as a Potential Source of Drugs Development in the Modern Era

Caves, the Mysterious World of Microorganisms

From cultural and natural heritage to reservoir of biomedicine: Prospection of bioactive compounds produced by bacterial isolates from caves

The geomicrobiology of limestone, sulfuric acid speleogenetic, and volcanic caves: basic concepts and future perspectives

Actinomycetes from Caves: An Overview of Their Diversity, Biotechnological Properties, and Insights for Their Use in Soil Environments

Composition and functional profiles of microbial communities in two geochemically and mineralogically different caves

Mining Actinomycetes for Novel Antibiotics in the Omics Era: Are We Ready to Exploit This New Paradigm?

The World of Cave Microbiomes: Biodiversity, Ecological Interactions, Chemistry, and the Multi-Omics Integration

Cryosphere: a frozen home of microbes and a potential source for drug discovery

Genome mining and prospects for antibiotic discovery

The Science of Antibiotic Discovery

Ancient and remote quartzite caves as a novel source of culturable microbes with biotechnological potential

Strategies to access biosynthetic novelty in bacterial genomes for drug discovery

Genome mining for the search and discovery of bioactive compounds: The Streptomyces paradigm

Marine Bacteriocins: An Evolutionary Gold Mine to Payoff Antibiotic Resistance

Genome Mining as New Challenge in Natural Products Discovery

Actinomycetota bioprospecting from ore-forming environments

Bioprospecting for Antibacterial Drugs: a Multidisciplinary Perspective on Natural Product Source Material, Bioassay Selection and Avoidable Pitfalls

Antimicrobials from endophytes as novel therapeutics to counter drug-resistant pathogens

Deep-Sea Fungi Could Be the New Arsenal for Bioactive Molecules.